Cross Country Healthcare buy melinda
Start price
05.09.12
/
50%
€3.54
Target price
05.03.13
€4.00
Performance (%)
23.42%
End price
05.03.13
€4.36
Summary
This prediction ended on 05.03.13 with a price of €4.36. The BUY prediction by melinda finished with a performance of 23.42%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cross Country Healthcare | -4.516% | -4.516% | -57.471% | -70.400% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% | 61.776% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% | 105.171% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% | 52.222% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% | 66.580% |
Comments by melinda for this prediction
In the thread Cross Country Healthcare diskutieren
klinischen Studien
Langlauf und Gesundheitsdienstleister von klinischen Studien andere Dienste Human Capital Management konzentriert sich auf Gesundheits-
(Laufzeit überschritten)
Stopped prediction by melinda for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€7.30
21.12.13
21.12.13
€5.50
23.06.14
23.06.14
-34.93%
23.06.14
23.06.14
